Clinical Trial Update: Ex Vivo Stimulation of Whole Blood as a Means to Determine Glucocorticoid Sensitivity to Mild-to-Moderate and Refractory Asthmatics

View source ↗

Summary

A clinical trial evaluating ex vivo stimulation of whole blood to determine glucocorticoid sensitivity in mild-to-moderate and refractory asthma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Jeanette Marketon, MD | Conditions: Asthma | Status: TERMINATED